cefuroxime has been researched along with Acute Cholecystitis in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Loozen, CS | 1 |
Kortram, K | 1 |
Kornmann, VN | 1 |
van Ramshorst, B | 1 |
Vlaminckx, B | 1 |
Knibbe, CA | 1 |
Kelder, JC | 1 |
Donkervoort, SC | 1 |
Nieuwenhuijzen, GA | 1 |
Ponten, JE | 1 |
van Geloven, AA | 1 |
van Duijvendijk, P | 1 |
Bos, WJ | 1 |
Besselink, MG | 1 |
Gouma, DJ | 1 |
van Santvoort, HC | 1 |
Boerma, D | 1 |
1 trial available for cefuroxime and Acute Cholecystitis
Article | Year |
---|---|
Randomized clinical trial of extended versus single-dose perioperative antibiotic prophylaxis for acute calculous cholecystitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cefuroxime | 2017 |